LightPath Technologies is a vertically integrated provider of optics and infrared imaging systems for defense and commercial customers, built around its proprietary BlackDiamond chalcogenide-based glass. The company closed fiscal 2026 with revenue nearly doubling to $71.7 million and a 197% surge in backlog to $110.9 million, reflecting its shift from lower-margin components toward higher-value assemblies, modules, and camera systems. This first-quarter report matters because it will show whether that momentum carried into fiscal 2027. I’m watching whether non-cash earnout charges tied to recent acquisitions continue to obscure the company’s underlying operational progress, and how management addresses production-capacity and supply-chain bottlenecks at a time of strong defense demand. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Consensus estimates for the first quarter of fiscal 2027 call for revenue of approximately $22 million, with forecasts ranging from about $21.9 million to $22.2 million, and a net loss of around $0.02 per share. That compares with revenue of $15.1 million and a loss of $0.07 per share in the first quarter of fiscal 2026, implying meaningful year-over-year top-line growth of roughly 45% or more.
For context, in the fourth quarter of fiscal 2026 LightPath reported record revenue of $21.2 million, gross margin of 39.4%, and adjusted EBITDA of $2.1 million — its fourth consecutive quarter of positive adjusted EBITDA — while still posting a GAAP net loss of $0.06 per share. Analysts will be watching whether gross margin holds near the high-30% range, whether operating expenses remain elevated as the company scales capacity, and whether any additional non-cash earnout fair-value adjustments affect the bottom line. From what I see, the adjusted EBITDA trend offers a clearer view of operational health than GAAP results alone.
Sentiment heading into this report is generally constructive but measured. LightPath shares have been volatile, reflecting both enthusiasm over the company’s rapid defense-driven revenue growth and concern about persistent GAAP net losses and rising operating expenses. The stock historically produces outsized post-earnings moves in either direction, and the options market implies a meaningful single-day swing around this announcement.
Key risk factors include any sign that gross-margin expansion is stalling, a larger-than-expected non-cash earnout charge, or commentary indicating that supply-chain constraints on detectors and glass are delaying deliveries. Conversely, evidence of continued backlog growth, sustained positive adjusted EBITDA, or progress converting program wins into production revenue could support the shares.
Beyond the headline figures, investors should focus on several forward-looking signals that management is likely to address on the earnings call.
First, backlog composition and delivery timing matter. At the end of fiscal 2026, roughly $85.6 million of the $110.9 million backlog was requested for delivery within 12 months, and management reported two large orders totaling $24 million shortly after the quarter ended. Commentary on how quickly these orders convert to revenue will shape expectations for the rest of fiscal 2027.
Second, capacity and supply constraints remain a central theme. Management has described specialty glass as its biggest production bottleneck and noted lengthening lead times for detectors. Any update on capital-expenditure plans and progress toward expanding manufacturing across its Orlando, Texas, New Hampshire, and Latvia facilities will be closely read.
Third, watch the non-cash acquisition earnout adjustments. These charges have distorted reported net losses and are likely to continue until earnouts tied to recent acquisitions are settled. Investors should distinguish these one-time items from the company’s underlying adjusted-EBITDA trend.
Finally, the planned divestiture of the company’s China subsidiary — a move aimed at aligning with U.S. defense-customer requirements — will remove a portion of annual revenue from consolidated results and could affect near-term top-line comparisons. Balancing that transition against strong demand from counter-drone and infrared-imaging programs will be a key focus as the year unfolds.
In my day-to-day analysis, Tickeron’s AI Screener has become a regular part of how I compare companies like LightPath to peers in defense and optics. It lets me quickly filter by fundamentals, technical patterns, and sector trends, which helps surface context I might otherwise miss when preparing for earnings like this one. The tool has saved me time when scanning for comparable names and monitoring momentum shifts across the group.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
LPTH saw its Momentum Indicator move above the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In 83 of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LPTH's RSI Oscillator exited the oversold zone, 19 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 62 cases where LPTH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for LPTH just turned positive on November 09, 2026. Looking at past instances where LPTH's MACD turned positive, the stock continued to rise in 41 of 50 cases over the following month. The odds of a continued upward trend are 82%.
Following a +30.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where LPTH advanced for three days, in 197 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
LPTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LPTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for LPTH entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.308) is normal, around the industry mean (3.856). P/E Ratio (-18.579) is within average values for comparable stocks, (6.228). LPTH's Projected Growth (PEG Ratio) (1.950) is slightly higher than the industry average of (0.930). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (7.003) is also within normal values, averaging (4.422).
The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. LPTH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of optical products
Industry ElectronicComponents